TY  - JOUR
AU  - Shaya, Justin A.
AU  - McKay, Rana R.
PY  - 2019
TI  - Immunotherapy combinations transform the treatment paradigm for advanced renal cell carcinoma
JF  - Annals of Translational Medicine; Vol 7, Supplement 8 (December 31, 2019): Annals of Translational Medicine
Y2  - 2019
KW  - 
N2  - Over the past 15 years, the treatment options for patients with advanced renal cell carcinoma (RCC) have undergone tremendous transformation. From single agent vascular endothelial growth factor (VEGF) targeted therapy, to now immunotherapy combinations, survival is improving given the results of landmark clinical trials which have expanded treatments for patients.
UR  - https://atm.amegroups.org/article/view/33634